dr. bryce on treatment selection in nonmetastatic castration-resistant prostate cancer
Published 4 years ago • 112 plays • Length 1:23Download video MP4
Download video MP3
Similar videos
-
1:08
dr. bryce on ongoing research in prostate cancer
-
1:45
dr. choudhury on antiandrogen treatment selection in nonmetastatic crpc
-
1:27
dr. bryce on the fda approval of rucaparib in brca-mutant mcrpc
-
1:39
dr. bryce on ongoing research regarding cdk12 alterations in prostate cancer
-
1:42
dr. bryce on next-generation radiopharmaceuticals in prostate cancer
-
8:54
challenges in treating nonmetastatic castration-resistant prostate cancer
-
2:22
dr. hwang on treatment selection in metastatic castration-sensitive prostate cancer
-
2:06
dr. bryce on potential biomarkers of response to immunotherapy in prostate cancer
-
1:22
dr. bryce on the use of abiraterone versus docetaxel in patients with prostate cancer
-
8:45
clinical trials in nonmetastatic castration-resistant prostate cancer
-
1:07
dr. penson on treatment selection in metastatic hormone-sensitive prostate cancer
-
1:09
dr. fizazi on darolutamide-based therapy in nonmetastatic crpc
-
2:13
dr. beltran on using cfdna to detect castration-resistant neuroendocrine prostate cancer
-
1:04
dr. choudhury on treatment goals in nonmetastatic crpc
-
1:56
dr. oh on targeted treatment in metastatic castration-resistant prostate cancer
-
22:16
understanding non metastatic castration resistant prostate cancer with dr. hamilton
-
7:38
qol in nonmetastatic castration-resistant prostate cancer
-
0:59
dr. crawford on abiraterone versus enzalutamide in prostate cancer
-
0:52
dr. lawrence karsh on treatment sequencing in metastatic castration-resistant prostate cancer